An Open-Label, Dose-Finding, Pharmacokinetic, Safety and Efficacy Study of Bivalirudin in Children Between 6 Months and 18 Years of Age.
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2016
At a glance
- Drugs Bivalirudin (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- Acronyms UNBLOCK
- 27 Jun 2011 Planned end date changed from 1 Sep 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
- 09 Sep 2009 Planned end date changed from 1 Sep 2009 to 1 Sep 2010 as reported by ClinicalTrials.gov.
- 30 Dec 2008 New trial record.